🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

AS Kalceks — Licensed Medicines

29 medicines held by AS Kalceks on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 29 products held by AS Kalceks
MedicineActive substanceLicence holderStatus
Atracurium besilate 10 mg/ml solution for injection/infusion
PA2165/001/001
Atracurium besilate AS Kalceks Marketed
Ceftriaxone 1 g powder for solution for injection/infusion
PA2165/017/001
Ceftriaxone sodium AS Kalceks Not marketed
Ceftriaxone 2 g powder for solution for injection/infusion
PA2165/017/002
Ceftriaxone sodium AS Kalceks Not marketed
Cisatracurium 2 mg/ml solution for injection/infusion
PA2165/008/001
Cisatracurium Besilate, Cisatracurium AS Kalceks Marketed
Clindamycin 150 mg/ml solution for injection/infusion
PA2165/021/001
CLINDAMYCIN PHOSPHATE AS Kalceks Not marketed
Dexamethasone phosphate 4 mg/ml solution for injection/infusion
PA2165/014/001
Dexamethasone sodium phosphate AS Kalceks
Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion
PA2165/010/001
Dexmedetomidine AS Kalceks Marketed
Fentanyl 50 micrograms/ml solution for injection
PA2165/011/001
Fentanyl AS Kalceks Marketed
Folinic acid (as calcium folinate) 10 mg/ml solution for injection/infusion
PA2165/024/001
Calcium folinate AS Kalceks Marketed
Hydromorphone hydrochloride 20 mg/ml solution for injection/infusion
PA2165/023/001
Hydromorphone hydrochloride AS Kalceks Marketed
Hydromorphone hydrochloride 50 mg/ml solution for injection/infusion
PA2165/023/002
Hydromorphone hydrochloride AS Kalceks
Levetiracetam 100 mg/ml concentrate for solution for infusion
PA2165/025/001
Levetiracetam AS Kalceks Not marketed
Levosimendan 2.5 mg/ml concentrate for solution for infusion
PA2165/015/001
Levosimendan AS Kalceks Marketed
Meropenem 1 g powder for solution for injection/infusion
PA2165/016/002
Meropenem Trihydrate AS Kalceks Not marketed
Meropenem 500 mg powder for solution for injection/infusion
PA2165/016/001
Meropenem Trihydrate AS Kalceks Not marketed
Midazolam 1 mg/ml solution for injection/infusion
PA2165/012/002
Midazolam AS Kalceks
Midazolam 5 mg/ml solution for injection/infusion
PA2165/012/001
Midazolam AS Kalceks
Morphine sulfate 10 mg/ml Solution for Injection
PA2165/003/001
Morphine sulfate AS Kalceks Marketed
Morphine sulfate 15 mg/ml Solution for Injection
PA2165/003/002
Morphine sulfate AS Kalceks
Morphine sulfate 30 mg/ml Solution for Injection
PA2165/003/003
Morphine sulfate AS Kalceks Marketed
Morsadex 50 mg/2 ml solution for injection/infusion
PA2165/002/001
Dexketoprofen trometamol AS Kalceks Marketed
Noradrenaline (Norepinephrine) 1 mg/ml concentrate for solution for infusion
PA2165/009/001
Noradrenaline AS Kalceks Marketed
Ondansetron 2 mg/ml solution for injection/infusion
PA2165/013/001
Ondansetron AS Kalceks Marketed
Oxycodone hydrochloride 10 mg/ml solution for injection/infusion
PA2165/005/001
OXYCODONE HYDROCHLORIDE AS Kalceks Marketed
Oxycodone hydrochloride 50 mg/ml solution for injection/infusion
PA2165/005/002
OXYCODONE HYDROCHLORIDE AS Kalceks
Pantoprazole 40 mg powder for solution for injection
PA2165/020/001
Pantoprazole sodium sesquihydrate AS Kalceks Not marketed
Rocuronium bromide 10 mg/ml solution for injection/infusion
PA2165/004/001
Rocuronium bromide AS Kalceks Marketed
Sodium oxybate 500 mg/ml oral solution
PA2165/007/001
Sodium Oxybate AS Kalceks Not marketed
Sugammadex 100 mg/ml solution for injection
PA2165/022/001
Sugammadex sodium AS Kalceks Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.